会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 44. 发明授权
    • Antiviral compounds
    • 抗病毒化合物
    • US5310745A
    • 1994-05-10
    • US929325
    • 1992-08-13
    • Richard A. PartisFrancis J. KoszykRichard A. Mueller
    • Richard A. PartisFrancis J. KoszykRichard A. Mueller
    • C07D211/46C07D401/06C07D491/04A61K31/445
    • C07D401/06C07D211/46C07D491/04
    • A method of inhibiting lentivirus is disclosed which comprises mammalian host susceptible to said lentivirus with a virally inhibitory effective amount of an O-acylated derivative of 1,5-dideoxy-1,5-imino-D-glucitol and their N-alkyl, N-acyl and N-aroyl derivatives in which from one to four of the free hydroxyl groups are O-acylated with carboxylic alkanoyl radicals selected from the group consisting of .omega.,.omega.,.omega.-trifluoroalkanoyl having from three to eight carbon atoms, carboxylic cycloalkanoyl groups having from four to eight carbon atoms and carboxylic acyclic alkanoyl groups having from two to ten carbon atoms, wherein the N-aroyl groups contain from 7 to 14 carbon atoms, the N-acyl groups contain from 4 to 8 carbon atoms and the N-alkyl groups contain from 1 to 14 carbon atoms.
    • 公开了一种抑制慢病毒的方法,其包括对所述慢病毒敏感的哺乳动物宿主,其具有病毒抑制有效量的1,5-二脱氧-1,5-亚氨基-D-葡萄糖醇的O-酰化衍生物及其N-烷基,N 酰基和N-芳酰基衍生物,其中1至4个游离羟基与选自具有3至8个碳原子的ω,ω,ω-三氟烷酰基的羧基烷酰基进行O-酰化,羧基环烷酰基 具有4至8个碳原子和具有2至10个碳原子的羧酸非环烷酰基,其中N-芳酰基含有7至14个碳原子,N-酰基含有4至8个碳原子, 烷基含有1至14个碳原子。
    • 45. 发明授权
    • Cyclic phenolic thioethers
    • 环状酚类硫醚
    • US5250567A
    • 1993-10-05
    • US903832
    • 1992-06-24
    • Richard A. MuellerRichard A. Partis
    • Richard A. MuellerRichard A. Partis
    • C07C323/20C07C323/52C07C323/60C07C323/65C07D213/40C07D307/20A61K31/34
    • C07D213/40C07C323/20C07C323/52C07C323/60C07C323/65C07D307/20C07C2101/08C07C2101/14C07C2103/66C07C2103/74
    • The compounds of the present invention comprise substituted phenolic thioethers represented by the formula (I): ##STR1## wherein: R.sup.1 and R.sup.2 are the same or different and independently represent tert-alkyl or phenyl; R.sup.3 represents hydrogen or alkyl; X represents --(CH.sub.2).sub.w --B--(CH.sub.2).sub.y -- wherein B represents O, S, or CH.sub.2 and w and y can each independently be an integer from 0 to 3 with the proviso that the sum of w+y is equal to or less than 3; A represents O or S(O).sub.n wherein n is 0, 1 or 2; p is an integer from 1 to 4; and R represents alkyl; OH; OR.sup.4 wherein R.sup.4 is alkyl of 1 to 4 carbon atoms; NR.sup.5 R.sup.6 wherein R.sup.5 is hydrogen or alkyl and R.sup.6 is hydrogen, alkyl, heterocyclealkyl in which the hetercyclic ring may optionally be substituted; cycloalkyl; substituted cycloalkyl; phenyl; substituted phenyl; phenylalkyl; or substituted phenylalkyl; or NR.sup.5 R.sup.6 together form a heterocyclic ring which may optionally be substituted; or R is (CH.sub.2).sub.t COOR.sup.7 wherein t is an integer from 1 to 4 and R.sup.7 is hydrogen or alkyl of 1 to 4 carbon atoms; and the pharmaceutically acceptable salts and stereoisomers or geometric isomers thereof. The compounds of the present invention are inhibitors of 5-lipoxygenase and therefore, are useful in the treatment of local and systemic inflammation, allergy and hypersensitivity reactions and other disorders in which agents formed in the 5-lipoxygenase metabolic pathway are involved.
    • 本发明的化合物包括由式(I)表示的取代的酚类硫醚:其中:R 1和R 2相同或不同并且独立地代表叔烷基或苯基; R3表示氢或烷基; X表示 - (CH 2)w B-(CH 2)y - ,其中B表示O,S或CH 2,w和y各自独立地为0至3的整数,条件是w + y的和等于或 小于3; A表示O或S(O)n,其中n为0,1或2; p是1至4的整数; 和R表示烷基; 哦; OR4,其中R4是1-4个碳原子的烷基; NR5R6其中R5是氢或烷基,R6是氢,烷基,杂环烷基,其中杂环可以被任选取代; 环烷基 取代的环烷基; 苯基; 取代的苯基; 苯基烷基; 或取代的苯基烷基; 或NR5R6一起形成可任选被取代的杂环; 或R为(CH 2)t COOR 7,其中t为1至4的整数,且R 7为氢或1至4个碳原子的烷基; 及其药学上可接受的盐和立体异构体或几何异构体。 本发明的化合物是5-脂氧合酶的抑制剂,因此可用于治疗局部和全身炎症,变态反应和过敏反应以及涉及5-脂氧合酶代谢途径中形成的药物的其它病症。
    • 47. 发明授权
    • 1,5-dideoxy-1,5-imino-d-glucitol derivatives
    • 1,5-二脱氧-1,5-亚氨基-d-葡萄糖醇衍生物
    • US5144037A
    • 1992-09-01
    • US639613
    • 1991-01-10
    • Richard A. PartisFrancis J. KoszykRichard A. Mueller
    • Richard A. PartisFrancis J. KoszykRichard A. Mueller
    • A61K31/445A61K31/4427A61K31/443A61K31/4433A61P31/12C07D211/46C07D401/06C07D405/06C07D409/06C07D491/04C07D491/056
    • C07D401/06C07D211/46C07D405/06C07D409/06C07D491/04
    • Antiviral O-acylated derivatives of 1,5-dideoxy-1,5-imino-D-glucitol are disclosed that contain an N-alkyl or N-aroyl radical in which from one to four of the free hydroxyl groups are O-acylated with carboxylic alkanoyl radicals selected from the group consisting of .omega.,.omega.,.omega.-trifluoro alkanoyl having from three to eight carbon atoms, carboxylic cycloalkanoyl groups having from four to eight carbon atoms and carboxylic acyclic alkanoyl groups having from two to ten carbon atoms, wherein the N-aroyl radical is selected from the group consisting of p-decylbenzoyl, 3-(p-chlorophenoxy)propanoyl, 2-(acetyloxy)benzoyl, [1,1'-biphenyl]-4-ylcarbonyl, 2-thiopheneacetyl, trans-3-furanacryloyl, 3-methoxyphenylacetyl and 3-(trifluoromethyl)benzoyl, and wherein the N-alkyl contains from one to fourteen carbon atoms, provided that when N-alkyl contains from one to five carbon atoms the O-acylated groups are .omega.,.omega.,.omega.-trifluoro alkanoyl or carboxylic cycloalkanoyl.
    • 公开了1,5-二脱氧-1,5-亚氨基-D-葡萄糖醇的抗病毒O-酰化衍生物,其含有N-烷基或N-芳酰基,其中一至四个游离羟基与O- 选自具有3至8个碳原子的ω,ω,ω-三氟烷酰基,具有4至8个碳原子的羧基环烷酰基和2至10个碳原子的羧酸非环烷酰基的羧基烷酰基,其中 N-芳酰基选自对 - 癸基苯甲酰基,3-(对氯苯氧基)丙酰基,2-(乙酰氧基)苯甲酰基,[1,1'-联苯] -4-基羰基,2-噻吩乙酰基, 3-呋喃丙酰基,3-甲氧基苯乙酰基和3-(三氟甲基)苯甲酰基,其中N-烷基含有1至14个碳原子,条件是当N-烷基含有1至5个碳原子时,O-酰化基团为ω, ω,ω-三氟烷酰基或羧基环烷酰基。
    • 50. 发明授权
    • Heterocyclic amides
    • 杂环酰胺
    • US4981853A
    • 1991-01-01
    • US436526
    • 1989-11-14
    • Richard A. MuellerRichard A. Partis
    • Richard A. MuellerRichard A. Partis
    • A61K31/495C07C319/02C07C323/20C07C323/52C07C331/10C07D207/16C07D295/18C07D295/185
    • C07D295/185C07C319/02C07C323/00C07C331/10C07D207/16
    • The compounds of this invention are heterocyclic amides represented by the formula: ##STR1## wherein: R.sub.1 and R.sub.2 are the same or different members of the group consisting of halo, phenyl, substituted phenyl and a ##STR2## group wherein q, r and t are independently an integer of from 1 to 8 provided that q+r+t is equal to or less than 10; Y is thio, sulfinyl or sulfonyl; Alk is straight or branched chain lower alkylene, and R.sub.3 is a heterocyclic amine represented by the formula: ##STR3## wherein R.sub.4 is selected from the group consisting of hydrogen, lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, carboxyl or carboxyloweralkyl; X is selected from the group consisting of N-R.sub.4, O and CH.sub.2 ; m is 2 or 3; n is 2 or 3 when X is O or N-R.sup.4, and n is 1 to 3 when X is CH.sub.2 ; p is 0 to 2; and the pharmaceutically acceptable salts thereof. The compounds are anti-inflammatory and anti-allergy agents.
    • 本发明的化合物是由下式表示的杂环酰胺:其中:R 1和R 2是由卤素,苯基,取代的苯基和基团组成的组中相同或不同的成员,其中q,r和t 独立地为1〜8的整数,条件是q + r + t等于或小于10; Y是硫代,亚磺酰基或磺酰基; Alk是直链或支链低级亚烷基,R3是下式表示的杂环胺:其中R 4选自氢,低级烷基,苯基,取代的苯基,苄基,取代的苄基,羧基或羧基低级烷基 ; X选自N-R 4,O和CH 2; m为2或3; 当X为O或N-R 4时,n为2或3,X为CH 2时n为1至3; p为0〜2; 及其药学上可接受的盐。 这些化合物是抗炎和抗过敏剂。